Oruka Therapeutics, Inc. Earnings

The next earnings date for Oruka Therapeutics, Inc. has not yet been scheduled.

Analyst Estimates of Oruka Therapeutics, Inc. Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Oruka Therapeutics, Inc. Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/12/2025	---	$-0.46	-6.36%
04/23/2025	Before Market	---	---
03/07/2025	---	$-0.64	---
11/04/2024	Before Market	$-1.91	-376.63%
08/27/2024	Before Market	$-2.22	---
04/26/2024	---	$-1.66	---
02/02/2024	---	$-0.90	---
11/07/2023	---	$-1.19	---
07/24/2023	---	$-1.23	---
05/09/2023	---	$-1.12	---
02/27/2023	---	$-0.98	---
11/09/2022	---	$-1.94	---
08/03/2022	---	$-2.62	---
05/03/2022	---	$-2.72	---
03/15/2022	---	$-4.73	---
11/03/2021	---	$-3.92	---
08/05/2021	---	$-4.03	---
05/12/2021	---	$-3.98	---
03/19/2021	---	$-6.44	---
11/02/2020	---	$-3.95	---
08/06/2020	---	$-8.71	---
05/07/2020	---	$-9.94	---
02/19/2020	---	$-9.23	---
11/07/2019	---	$-9.12	---
08/02/2019	---	$-13.64	---
05/09/2019	---	$-22.29	---
02/28/2019	---	$-23.10	---
11/15/2018	---	$-24.71	---
08/10/2018	---	$-32.83	---
05/09/2018	---	$-43.37	---
03/23/2018	---	$-76.99	---
11/10/2017	---	$-83.24	---
08/15/2017	---	$-127.91	---
05/15/2017	---	$-103.03	---
03/22/2017	---	$-100.93	---
11/15/2016	---	$-110.97	---
08/10/2016	---	$-92.78	---
05/12/2016	---	$-87.01	---
03/18/2016	---	$-75.60	---
11/13/2015	---	$-67.28	---
08/12/2015	---	$-148.61	---
05/13/2015	---	$-196.00	---
03/20/2015	---	$-186.65	---
11/13/2014	---	$-164.22	---
08/14/2014	---	$-173.08	---
05/14/2014	---	$-192.29	---
03/21/2014	---	$-283.98	---
11/13/2013	---	$-240.50	---
08/14/2013	---	$-986.26	---
05/14/2013	---	$-533.60	---
02/28/2013	---	$-571.20	---
11/02/2012	---	$-613.74	---
08/07/2012	---	$-854.53	---
05/08/2012	---	$-1,049.15	---
03/01/2012	---	$-1,473.10	---
10/28/2011	---	$-1,574.29	---
08/09/2011	---	$260.21	---
05/10/2011	---	$-2,265.30	---
03/03/2011	---	$-1,701.07	---
10/29/2010	---	$-2,166.71	---
08/10/2010	---	$-2,358.16	---
05/11/2010	---	$-2,907.85	---
02/25/2010	---	$-7,912.70	---
10/30/2009	---	$-5,158.52	---
08/11/2009	---	$-10,297.06	---
05/08/2009	---	$11,586.09	---
02/26/2009	---	$-1,000,000.00	---
10/31/2008	---	$-1,000,000.00	---
07/24/2008	---	$-984,225.19	---
05/09/2008	---	$-1,000,000.00	---
02/28/2008	---	$-39,536.99	---
11/02/2007	---	$-48,820.59	---
08/02/2007	---	$98,771.87	---
05/09/2007	---	$-52,297.05	---
02/27/2007	---	$-223,861.09	---
11/02/2006	---	$-93,011.46	---
08/03/2006	---	$-66,146.83	---
05/05/2006	---	$-72,894.27	---
02/27/2006	---	$-90,821.46	---
11/01/2005	---	$-79,434.60	---
08/04/2005	---	$-73,423.04	---
05/02/2005	---	$-70,080.96	---
02/15/2005	---	$-70,271.54	---
11/09/2004	---	$-61,629.16	---
08/09/2004	---	$-62,396.69	---
05/06/2004	---	$-117,100.37	---
02/05/2004	---	$-67,591.86	---
10/30/2003	---	$-92,820.59	---
07/31/2003	---	$-140,568.66	---
05/01/2003	---	$-148,954.35	---
10/24/2002	---	$-34,523.57	---
07/25/2002	---	$-199,119.22	---
04/25/2002	---	$-551,064.05	---
02/06/2002	---	$-332,035.15	---
10/25/2001	---	$-322,130.85	---

More About Oruka Therapeutics, Inc.

Website

https://orukatx.com

Country

USA

Full Time Employees

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

“Oruka Therapeutics, Inc. Earnings” Can Refer to the Oruka Therapeutics, Inc. Earnings Date

Some people say “Oruka Therapeutics, Inc. earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Oruka Therapeutics, Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Oruka Therapeutics, Inc. Stock on the Earnings Date

If you own Oruka Therapeutics, Inc. stock (ORKA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Oruka Therapeutics, Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Oruka Therapeutics, Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Oruka Therapeutics, Inc. Earnings

You can contact us any time if you would like to ask questions about Oruka Therapeutics, Inc. earnings or anything else related to the stock market.